🔬 Siphtor← Home
EngineSiphtor Multi-Agent Research Pipeline
CoverageGlobal Macro / Trade Telemetry / Corporate Filings
Run Duration3m 46s
StatusLive Autonomous Briefing

Siphtor Research

Mitsui Chemicals Reports 123.4% Jump in Core Operating Profit

Mitsui Chemicals reported a 123.4% year-over-year increase in core operating profit for the first half of fiscal 2027, as favorable trading conditions and rising raw material prices boosted revenue. The company’s core operating profit reached ¥99.3 billion, a substantial increase from the ¥44.5 billion recorded in the same period last year. Sales revenue grew by 20.3% to ¥979.1 billion, primarily due to price revisions linked to naphtha costs and exchange rate fluctuations.

By Siphtor Media

Published: 11/17/2026

Mitsui Chemicals Reports 123.4% Jump in Core Operating Profit

Mitsui Chemicals reported a 123.4% year-over-year increase in core operating profit for the first half of fiscal 2027, as favorable trading conditions and rising raw material prices boosted revenue. The company’s core operating profit reached ¥99.3 billion, a substantial increase from the ¥44.5 billion recorded in the same period last year. Sales revenue grew by 20.3% to ¥979.1 billion, primarily due to price revisions linked to naphtha costs and exchange rate fluctuations.

This significant profit jump comes alongside the announcement of two major strategic moves: the acquisition of Ultradent Products, Inc. and a planned consolidation with JSR Corporation. The acquisition of Ultradent, a US-based dental materials company, strengthens Mitsui Chemicals’ foothold in the oral care market, adding to its existing business through Kulzer GmbH. The company believes this will create synergies and accelerate growth in the high-growth oral care segment. Simultaneously, Mitsui Chemicals is integrating with JSR through a series of transactions, aiming to become a leading specialty chemical company, particularly in semiconductor materials. This will involve a substantial investment, with plans for a ¥1,500 billion equity offering.

While the company’s operating performance improved significantly, the balance sheet reflects increased debt levels. The ratio of net debt to equity rose to 0.84, up from 0.70 in the previous fiscal year, driven by increased borrowing. Despite this, the company maintained a healthy asset-to-liability ratio. The company also completed a 2-for-1 stock split, effective January 1, 2026, intended to improve the accessibility of its shares.

Looking ahead, Mitsui Chemicals is focused on strengthening its presence in specialty chemicals, particularly in the semiconductor sector, and improving its financial position. The company expects to see a combined incremental profit of ¥40 billion per year from the JSR integration, and is aiming to maintain a strong financial base while pursuing growth opportunities. These moves suggest a deliberate shift towards higher-margin, technology-driven businesses, positioning Mitsui Chemicals for long-term sustainable growth.

TSE_MITSUI_CHEMICALS_INCTSE_MITSUI_CHEMICALS_INC • Corporate Filing Telemetry
Open & Model This Dataset in Siphtor AI

Enjoyed this article?

Siphtor Media subscribers get unlimited articles, interactive charts, and the full economic data dashboard — starting at $7.99/month.

Free newsletter · No spam · Unsubscribe anytime

Keep Exploring

Mitsui Chemicals Reports 123.4% Jump in Core Operating Profit | Siphtor